Article ID Journal Published Year Pages File Type
8724473 Revista Argentina de Endocrinología y Metabolismo 2016 10 Pages PDF
Abstract
Tyrosine kinase inhibitors are used for the treatment of different types of tumours, interfering in various cell proliferation pathways, and tumour angiogenesis. These oral agents have side effects, thyroid dysfunction outstanding among them. There are different mechanisms through which these agents lead to hypothyroidism, as well as thyrotoxicosis. There is still no consensus on the treatment and follow-up of the above mentioned effects.
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Authors
, , ,